biote Corp. BTMD
1.22
(0.01)
(0.81%)
as of 25 Sep
- Market cap
- $44.2M
- P/E
- 7.8×
Follow BTMD
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (8.55%) | (23.50%) | (35.45%) | (29.95%) |
+8 more TTM periods Free account |
|
| 5.67% | 14.69% | 23.52% | 27.09% | ||
ROIC |
17.68% | 34.62% | 68.34% | 199.50% | |
Return on Tangible Assets |
22.71% | 82.86% | 132.37% | 264.70% | |
Average Days of Receivables |
15.53 | 14.35 | 13.04 | 14.87 | |
Free Cash Flow per Share |
0.61 | 0.86 | 0.91 | 1.10 | |
Free Cash Flow |
17.52 | 26.45 | 28.33 | 34.41 | |
Capital Expenditures |
(6.85) | (6.18) | (6.86) | (5.58) | |
Piotroski F-Score |
4.00 | 4.00 | 6.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
32.72% | 51.76% | 43.58% | 60.63% | |
Accounts Receivable Turnover |
21.74 | 24.82 | 26.51 | 23.77 | |
Accounts Payable Turnover |
11.05 | 9.72 | 8.68 | 12.38 | |
Inventory Turnover |
3.79 | 3.37 | 3.24 | 3.31 | |
Average Days of Payables |
41.62 | 53.46 | 45.42 | 29.43 | |
Days of Inventory on Hand |
116.02 | 129.05 | 126.84 | 111.04 | |
Tax Rate |
(0.31) | (0.21) | (0.16) | 0.06 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
60.54% | 54.69% | 52.97% | 56.27% | |
Share Based Compensation of Revenue |
4.54% | 4.55% | 4.64% | 4.40% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.16 | 2.09 | 1.30 | 1.39 | |
Depreciation/Fixed assets |
0.36 | 0.43 | 0.42 | 0.47 | |
Capex/Depreciation |
(1.47) | (1.34) | (1.52) | (1.19) | |
Revenue per Share |
6.41 | 6.14 | 6.14 | 6.24 | |
Operating CF per Share |
0.85 | 1.06 | 1.13 | 1.28 | |
Capex per Share |
(0.24) | (0.20) | (0.22) | (0.18) | |
Capex to Sales |
0.04 | 0.03 | 0.04 | 0.03 | |
Net Profit Margin |
3.19% | 8.29% | 14.07% | 14.72% |
Columns are period end dates